169255-50-9

Basic information

• Product Name: Phenol, 2,6-diiodo-4-(trifluoromethyl)-
• CAS NO: 169255-50-9
• Molecular Formula: C7H3F3I2O
• Molecular Weight: 413.904
• Mol File: 169255-50-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Phenol, 2,6-diiodo-4-(trifluoromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 2,6-diiodo-4-(trifluoromethyl)-(169255-50-9)
• EPA Substance Registry System: Phenol, 2,6-diiodo-4-(trifluoromethyl)-(169255-50-9)

Safety Data

• Hazardous Substances Data: 169255-50-9(Hazardous Substances Data)

Upstream product

• 402-45-9 4-hydroxybenzotrifluoride 
• 463976-21-8 α,α,α-trifluoro-o-iodo-p-cresol 

Relevant articles and documents

Dearomatization/Deiodination of o-Iodophenolic Compounds with α,β-Unsaturated Imines for Accessing Benzofuran Derivatives

A dearomatization/deiodination/rearomatization strategy for the [3 + 2] cyclization of o-iodophenolic substrates with α,β-unsaturated imines to construct various dihydrobenzofuran-related skeletons has been established. Tolerance to different functional g

NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, inflammatory disease of the joints, neuropathies, HIV-related neuropathy, nerve injury, neurodegeneration, stroke, urinary bladder hypersensitivity including urinary incontinence, cystitis, stomach duodenal ulcer, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), fecal urgency, gastro-esophageal reflux disease (GERD), Crohn's disease, asthma, chronic obstructive pulmonary disease, cough, neurotic/allergic/inflammatory skin disease, psoriasis, pruritus, prurigo, irritation of skin, eye or mucous membrane, hyperacusis, tinnitus, vestibular hypersensitivity, episodic vertigo, cardiac diseases such as myocardial ischemia, hair growth-related disorders such as effluvium, alopecia, rhinitis, and pancreatitis.